Corvus Pharmaceuticals Inc (CRVS)
2.19
-0.03
(-1.35%)
USD |
NASDAQ |
May 16, 16:00
2.18
-0.01
(-0.46%)
After-Hours: 20:00
Corvus Pharmaceuticals Free Cash Flow: -20.98M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -20.98M |
| December 31, 2023 | -23.97M |
| September 30, 2023 | -26.35M |
| June 30, 2023 | -28.11M |
| March 31, 2023 | -29.01M |
| December 31, 2022 | -27.29M |
| September 30, 2022 | -26.60M |
| June 30, 2022 | -27.83M |
| March 31, 2022 | -34.35M |
| December 31, 2021 | -36.72M |
| September 30, 2021 | -38.07M |
| June 30, 2021 | -37.45M |
| March 31, 2021 | -34.29M |
| December 31, 2020 | -34.85M |
| September 30, 2020 | -35.16M |
| June 30, 2020 | -37.96M |
| March 31, 2020 | -37.69M |
| Date | Value |
|---|---|
| December 31, 2019 | -37.35M |
| September 30, 2019 | -37.22M |
| June 30, 2019 | -37.57M |
| March 31, 2019 | -39.30M |
| December 31, 2018 | -41.34M |
| September 30, 2018 | -43.92M |
| June 30, 2018 | -43.78M |
| March 31, 2018 | -44.67M |
| December 31, 2017 | -46.48M |
| September 30, 2017 | -45.53M |
| June 30, 2017 | -41.50M |
| March 31, 2017 | -36.66M |
| December 31, 2016 | -30.06M |
| September 30, 2016 | -24.84M |
| June 30, 2016 | -21.41M |
| March 31, 2016 | -16.68M |
| December 31, 2015 | -13.08M |
Free Cash Flow Range, Past 5 Years
-38.07M
Minimum
Sep 2021
-20.98M
Maximum
Mar 2024
-32.44M
Average
-34.60M
Median
Free Cash Flow Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.12M |
| Enanta Pharmaceuticals Inc | -113.29M |
| Oragenics Inc | -7.291M |
| Nanoviricides Inc | -6.203M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.157M |
| Cash from Investing (Quarterly) | -0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.1052 |
| Free Cash Flow Yield | -19.70% |